Recently, two studies with rodent models of colitis reported a decrease in disease severity after KCNN4 inhibition [70], [71], which seems to contradict our hypothesis of beneficial effects of KCNN4 activation on mucosal healing under inflammatory conditions. This evidence concerns the gene KCNN4 and colitis.